Transcript Disclaimer – Please note that the following transcript has been machine generated by an AI software and therefore may include errors or omissions.

Robin Daly
Hi and welcome to the Yes to Life show. My name is Robin Daly, host of the show and founder of Yes2Life, the UK’s integrative cancer care charity, helping people to find out what they can do to help themselves through cancer and cancer treatment. My guest today is a veteran of the show, indeed a veteran of integrative cancer care. Patricia Peat founded cancer options some years before Yes to Life arrived on the scene and was one of the very first reliable sources for information about integrating lifestyle and complementary approaches alongside conventional care. Patricia has taken the cancer option service from strength to strength and now recently initiated the Peat Institute to train others in integrative cancer support. Great have you back on the show again.

Patricia Peat
Robin, always a pleasure.

Robin Daly
It’s actually been more than a year since your last time, would you believe?

Robin Daly
So the main aim of the chat today is to catch up on development of cancer options on the Peter Institute and to look forward to what’s in the pipeline for the rest of the year and onward. But first I’d like to take a few moments to go right back to the dawning of cancer options which must have been more than two decades ago now.

Patricia Peat
I haven’t got the right property to blame it. Can you take us… In a land long, long ago. Yeah, it was.

Robin Daly
Can you take us right back to the thoughts and experiences that they’re due to set up Ken’s options in the first place.

Patricia Peat
Yeah. Oh my word. Gosh, it is a long time ago. Um, and essentially it was, yep. So there I was running chemotherapy clinics, dispensing, looking after people, specializing in lymphomas and GIs. So pancreatic, esophagus, all the difficult GI stuff. Um, and, uh, you know, a gradual realization that, gosh, it wasn’t achieving a great deal a lot of the time. And, um, I, I, you know, the thing I refer to most is I couldn’t answer anybody’s questions. I was being, you know, I’m a very inquisitive person. I was being asked, you know, how do I stop losing weight? How do I get energy back? Uh, you know, uh, you know, how do I deal with these side effects? Uh, look, you know, what we did was so limited in that. Um, so I, you know, I, I, I was looking at that and then I think I mentioned to you before I had some clients who were integration, doing IV bit C, doing diets, et cetera. And one lady in particular, Jillian, who remains fond in my memory, even, you know, we’re going to go back about 30, 35 years now. And, uh, she was just a phenomenon. Um, you know, she, she would, she did so well against the cancer. She did, she was knocking it out of the park. She was full of energy. She, yeah, she used to boom through the oncology doors and she, you know, she didn’t bear Nick the noise. And I felt, well, you know, we’re not, we’re not the clever ones. So I got talking to her, got used to what she was doing and other people as well. And I just thought, well, I’m really, are we the most intelligent people here? And I actually was very excited about what I was finding, what was going off. I thought everyone’s going to be interested in the medical world. And I was going home to my dear husband, Mike, who’s always been amazing. I say to him, I get very frustrated and say, you know, there’s so much that people can do to help support themselves, to feel better, to get better, but nobody talks about it. Well, you know, we’re not allowed to. I said, somebody needs to set up a consultancy or something so that people get to know what their options are.

Patricia Peat
Yeah, and he did utter the awful words, you know, well, somebody, why not you? And then this was coupled up with Julia, and I kind of started discussing with her, and then every time I saw her, she was like, have you done it yet? Have you done it yet? Why not? Why not? Why is it not happening? I’m going, it became easier to do it than not to do it. Peter Wright. But it was a weird thing to be quiet. I look back now and you think, what’s that math? Because it’s not a look back thing. It does look slightly bold, because doesn’t it leave a job and a pension and security and all that. And it was an absolute vacuum at the time. I think you emerged a few years later to make a company like you for that. So there wasn’t, you know, there wasn’t a lot going on. There wasn’t. And I used to, at one point, when I first started, obviously, I was, you know, I had to sort of keep some money coming in to the family home. And I used to actually go to work at nights on the medical, I was working in an agency. I used to go to work at nights on medical emergencies. And I’d get a bed in the morning with the phone and a pad and a pen. So if anybody rang, I would suddenly jerk myself awake at times. I’d brighten up, hello, cancer option. Yeah, it was as bad as that. But that’s what it took. And gradually start, you know, very slowly started, you know, so I was juggling everything. But all the time, learning and learning and learning. And it astonishes me how much I learned, but the fact that I’m still learning at the same rate now.

Robin Daly
The ball park is moving, isn’t it? Very fast. Oh my word. It’s a good sight, isn’t it? It’s a great sight that actually we’re understanding much more. It’s fantastic. Yeah, the pace has gone up significantly.

Patricia Peat
Well, the pace has gone up, the knowledge, the ability to research, to get that precise information about what’s happening to individual people, and to metabolic system, nominal, to work very precisely with people now. So, you know, I must say in the older days, it was more generalized, but now we can be, you know, I often say a lot of the time people, one of the big issues is people come in to go to medicine and doing a lot of things to fear of missing out on something rather than really knowing what is going off. So, you know, our job is to preside that precision and, you know, that’s improved. The results have improved enormously. The knowledge and the, you know, I often say my clients, you will know far more about yourself and your cancer than your oncologist ever will. And that’s true. They become their own experts. So, you know, so the whole area has now, you know, and you look at what’s going on around the world and integration, I’ve got one of my clients, no, one of my students is launching integrative oncology in China, and has got some doctors on board and she’s taking everything that I’m teaching her and launching it in China and America, you know, and everywhere it’s so exciting. That’s exciting in the UK because, you know, they need to get going, but yeah, no, it is. It’s quite remarkable when we look back.

Robin Daly
Yeah, well, I was certainly with you on the fact there wasn’t much around in those days. It didn’t take me long to find you. I remember you were about all that was happening. Yeah, we met up at a conference very early on and I remember. We did. We did.

Patricia Peat
Yeah, when we were young and full of fun. That’s good. Full-ish. Full-ish, yeah.

Robin Daly
Anyway, so I wonder if you could tell us a little bit about the climate really for integration back then. I mean to be fair, integration wasn’t really a term in use then, was it? It really was.

Patricia Peat
It really wasn’t. It was still classified, alternative, very much, and to be fair, there had been a fair few wacky things around. There have been a fair few wacky things around. Inevitably, yeah. Inevitably, and because of lack of research and lack of good information, people were very susceptible to that, and you’d often come across people who were doing something and you’d think, oh, really, I don’t think that’s quite the good idea. From that, there was an area of trying to protect their patients, a lot of oncologists were very anti-anything, in terms of at least you’re going to waste your money, B, you might do yourself some harm. There was a lot of negativity about it, and that was generalized across the board, and to some extent justified. What wasn’t recognized was that what was emerging was a whole process of understanding of metabolics that would come to what we have today, which is a science-based force to be reckoned with. That’s absolutely right. Still is not recognized yet for what it should be, which is absolutely essential.

Robin Daly
I’m glad you used the word metabolics there, because you’re right in as much as there’s an almost consistent thread of people who’ve sort of stayed outside the box, if you like, right away from Otto Warburg through, and have been treating people metabolically for cancer, whatever other people called them, because it helped. And yes, you’re right, it was all a lot more haphazard, but some things, to be fair, high dose vitamin C, since day one, has been doing a job for people with cancer, and it’s still doing it now, and it’s taken a horrendous slanging along the way, but you know, it’s an incredibly useful approach that’s still in use more than ever now than it was.

Patricia Peat
Yes, and now the research is very much emerging. It has been slow on that, slower than others. But yeah, and I think what’s been recognized is, and I would say years ago, okay, so in my early days, I would probably have to, to some degree, explain and sell the idea of why you would integrate both approaches or whatever, why it was a good idea. Nowadays, I don’t have to at all, or very little, people come along fully loaded, they’ve got it that standard of care is one dimensional, they’ve got it that there are a lot of negatives to it, that it’s having a detrimental effect on the immune system, on the gut, on everything else. And they’ve got it that they’re not going to get that information very much from the medical world. So, you know, they have to run their own show in that respect. And people are coming along, you know, sort of saying, okay, we understand the situation, we understand. And, you know, we are embracing this and we are empowering ourselves and we are, you know, we are doing it. And certainly since the emerging research on repurposed drugs as well, it’s really just, and learning all about the answers, you know, J.D. McLennan’s amazing work on learning all about the signaling pathways and the metabolic pathways, it’s emerged as a rightful contender, you know, to standard of care, either alongside or as a replacement, you know, as a choice for the individual.

Robin Daly
yeah no things are moved on enormously yeah so you know I think when you started up and when I arrived as well it was what was going on was less like integration and more like trench war for her but yeah but anyway it has moved on but far too slowly but and it definitely is moving now so anyway but probably the single thing that set your approach apart from the majority of anything else that was happening that time was that you were actually a renegade from Orthodox medicine yes with long experience on the oncology boards and therefore you got a broad appreciation for what actually was working with unconventional medicine and what wasn’t so it’s very different to attacking every single aspect which was a common tactic on yeah in the trenches on both sides of course you know the other side are gonna kill you basically and that hasn’t entirely been left behind even now but I wonder if you could talk a little bit about what it was like back then working within this environment and what you sought to achieve for your clients

Patricia Peat
It was, yeah, it was quite, it was hostile. No, no doubts about it. What used to frustrate me was the hostility didn’t come from a place of knowledge. They didn’t know what I was doing, what I was saying. You know, I’ve got, you know, I’ve studied cancer now every day for 35 years, whatever. You know, I’ve got great understanding of cancer. And for me, it’s very important that people understand how cancer behaves so that they understand that. And the trench warfare that we had then came, you know, it came from that, it came from a place of ignorance, really, particularly about nutrition, you know, is fear-based that, oh, if you go and get some nutrition advice from the other side, they will tell you to starve yourself to death, essentially. You know, they’ll tell you, we’re telling you that you should be nurturing yourself with donuts and mars balls and ice creams. They will tell you to eat nothing to starve cancer out the body, which is not true. It’s not what we were doing. We actually understood, you know, the metabolics. We understood Kakexia. We understood how to do these things in a proper way that enable people not to feed the cancer. And now we understand that even better. But it was very, it was, it was very hostile. We used to get a lot of negativity, but nothing ever direct. Nobody ever spoke to me. Nobody ever rang me up and asked me what I was doing, what I thought. Nobody wrote to me. There was just, you know, you get comments passed on all the time. I did have a habit at one point in my early days, actually, as I say, when I first got into this, I thought, wow, the medical profession is going to be so exciting when they hear about it. Don’t worry.

Patricia Peat
No, I didn’t. I was like, hey, look, everybody, this is like, and I go, hello, everybody, everybody. Um, so I still write to the Molson of you and say to them, um, uh, this is really interesting. A lot of it, you know, there’s emerging research, it’s more research-based and people are benefiting. Would you like me to come and do a talk for you? And then it’s ignore me. And then I wrote a year for about five years and then I gave up, kind of thing. So, but as I say, um, it was fear and ignorance that they were basing, you know, I still get it less and less and less now, but I still get it to some degree where they make a broad comment like oxygen will cause cancer to spread. Okay. Can you give me your rationale and research on that, please? No, but it will. And you shouldn’t, you shouldn’t look after the, you shouldn’t have probiotics. Well, can we look at the individual reasons why and why not for and what situations? Nope. Shouldn’t have, you know, so giving a broad base, you shouldn’t, you shouldn’t, um, not from a place of metabolic research and evidence base is not terribly clever. And even today, um, you know, without wishing to be disparaging, and I don’t often find, come across clients who’ve received dietetic advice from the doxoid that have actually found it helpful and makes sense and fits with their holistic view of how they want to deal with cancer.

Robin Daly
But it would also be fair to say that of course that kind of blanket hostility exists on both sides at that time, didn’t it? I mean, you had the… It did, yes. poison, that kind of language that used to come, don’t go in there, it’s just like certain death, basically.

Patricia Peat
It’s absolutely right. He used to frustrate me because I said, do you actually understand that sometimes I’m encouraging people to have chemotherapy when they don’t want to? Yes. Because I think it’s a good thing. Certainly the whole rationale for hormone therapy would go into cut out the hysteria that’s out there and talk to people about where the noise comes from. People who have issues with treatments are the ones who’ll go on the internet and talk about it. People who are fine won’t. I was going to be in a very balanced viewpoint to the whole thing and helping people come to format their protocols in the way that absolutely suits them. But yeah, no, it was coming from both sides and both was a slightly hysterical reaction. What do we want for anybody with cancer, Robin? We want them to get the absolute best out of everything.

Robin Daly
Absolutely right. Absolutely right.

Patricia Peat
best decisions make safe decisions and get the best results I don’t care what people do you know as long as it’s kind of the best decision that they have available

Robin Daly
Well, I can personally thank you for helping me to gain more appreciation for things like chemotherapy and what they can offer and under what circumstances. Oh, yes, I had to convert you, didn’t I? I was pretty quite negative myself about those kind of things when I started out, but it’s good to have a broader understanding that they had their place and they certainly do.

Patricia Peat
It’s easy to do so, and I think there are still situations where, yes, it’s a very poor argument for it, you know, depending on, but, you know, you can’t generalize, that’s my point. You can’t generalize, that’s too dangerous.

Robin Daly
So, you know, one of the most important realizations that I had around the early days of yes-to-life was that integrating those and asked the same basic question about all possible approaches as any person with cancer who’s looking to improve and link their life would be, which is, well, could this help me? That’s the intelligent question to ask about anything that’s presented to you. Yes. And, you know, the biggest problem, if you like, with the trench warfare, there’s no one actually standing alongside the person with cancer who’s asking that question. The person with cancer, they’re stumbling around in the no man’s land between the warring factions, getting hit in both directions. And both sides primarily preoccupied with having God right on their side and defending themselves. And most importantly, they’re preoccupied with winning the war.

Patricia Peat
Yeah. You’d often get somebody with cancer who’s going in, dreading that conversation with their oncologist and their oncology team, and perhaps getting different vibes from their own families. Instinctively, I want to do more and wider, but they’re getting push more sides. I said to Carol who works with me recently, she’s learning the area. I said, one thing that people get from here is they have conversations they can’t have anywhere else. To get that, you get my opinion, you get my approach, you get my point of view. That’s what’s so important with that. As I teach my students, it’s as much psychology as it is the metabolic. Absolutely. Yeah.

Robin Daly
You know, people who ring out the S-Life helpline are often got the first listening voice who’s not being judgmental about anything they’re saying about themselves or the treatment, and just listening in order to look to support them. It’s enormously empowering and important in some cases.

Patricia Peat
and we’re just setting up at the moment, we’re having to set up a group of our clients very happily. It’s a bizarre thing, isn’t it? Because we’ve got a lot of people, I’ve just noticed over the last sort of 18 months, so many people are perhaps going into remission and doing well, whether perhaps have been told that they weren’t going to, or it was unexpected. And that’s a weird place to be. You’re thinking, well, isn’t everybody happy? No, because it’s such a lot to deal with. And people, even though everyone’s like, oh, fantastic, you’re in remission. They’ve still got all that asserted to deal with, plans to make. Yeah. Psychologically, there’s a lot, and they’re still kind of like, yeah, there’s nobody else. And the Orthodox side, when they go to talk to them, they’ll still be really quite negative, and it’s such a weird place. So yeah.

Robin Daly
Well, you can offer the kind of support of good solid information to support them in the position they’re in, and that has a psychological effect in itself, having a kind of rational approach if you like to staying well, rather than keeping your fingers crossed.

Patricia Peat
Yeah. And, and, and to be able to provide the evidence to support it, you know, it’s very, you know, well, very evidence-based practice. Yeah. Well, that’s very.

Robin Daly
that’s fantastic for people as well and I think the other great thing that’s out there for people more and more these days and I can point to our own wigwam groups which are great for this is actually connecting to other people in a similar circumstances so you can actually support each other I think that’s magic I think it’s such a great thing

Patricia Peat
It’s absolutely, you know, we look internationally at what’s happening, Robin, and it is a movement now. It’s a movement that’s gathering in power, it’s a movement that’s gathering in numbers and research, and it’s a movement that’s gathering in energy and everything, you know, and that’s just a wonderful, wonderful thing. Absolutely. It’s a viable community of people moving together, learning together, you know, amazing. You look at the amount of conferences and everything that’s going on now that there never used to be anything.

Robin Daly
That’s right.

Patricia Peat
it’s going on all the time, which is fantastic.

Robin Daly
It’s really good. So with true integration, you could call that an agnostic approach because it’s beyond any particular dog magic beliefs. And last, there’s a focus there on what’s actually working for people and also a focus on them and their particular needs and desires for themselves. So it’s putting them at the centre.

Patricia Peat
It’s not putting cancer, it’s not putting cancer through the center. We’re not as an oncology, we’re just focused on the tumor. We’re talking about the tumor, the tumors, the tumor. That’s it. You know, and you’re like, Oh no, he’s attached to somebody. How wonderful. So yeah, they are the most important thing.

Robin Daly
So, you know, this is, if you like, this is the very heart of what it means to give patients and to care. Oh, totally. It’s actually a listening. And it’s what people want. Absolutely, of course. They don’t want to be ignored and treated like a tuba. I mean, you know, it’s absolutely obvious. So there you are. So you were actually integrating before integrating was a thing. Yes, I hadn’t been used that word. I don’t know when it came in exactly, but it seems like it was about 2007, 2009. I don’t know, somewhere around there.

Patricia Peat
We didn’t, we didn’t have a word, did we? Not really, it was fucking girls, you know. There were no words for us. No, not for proper integration.

Robin Daly
There weren’t. No. So anyway, I’m just interested, you tell us what you remember about the development of integration in cancer K, how it began to happen, how it began to be accepted.

Patricia Peat
Well, it’s just, it’s been a kind of moving forward, two things really. The amount of people who, like myself, who are curious and looking at research, and then the ability from the, both the scientific research and the metabolic testing to be able to analyze and know what we’re talking about and know what you’re looking at, that’s what’s driven change. Yeah. It is a big change. That’s what’s really driven change, yeah. And things like functional testing, where there’s one thing, there’s a functional testing, so there’s a lot of things you can find out exactly what’s underlying things and what’s happening to that. And then the ability to do genetic analysis from the orthodox side, map the whole genome and see what’s happening. So you match up what’s happening, but you build a picture of the person with as much information as possible, and then you match the orthodox approaches to the integrative approaches to, it becomes a game of chess, what to choose when. But it’s all done from finding out if someone’s got EGFR mutations, they might be offered a drug, but we can also, there could be purpose drugs and supplements that also work on that. And because of metabolic flexibility, that cancer will change and mutate and go down a different pathway. And you block it, as Joe McClellan pointed, you block all the different ways. So you come up cancer from many, many different ways, because the big issue, the big Achilles heel of the orthodox standard of care approach has always been metabolic flexibility. And this is what my conferences about in September, I’ve themed it on that because I think a lot of people kind of know cancer changes, but they don’t really understand what’s happening and that science is now telling us really what is happening there, that’s what we need to target. So everyone knows that people are given chemotherapy and then it comes back and they say, oh, that’s stopped working. So what does that mean? What’s happening when it’s stopped working? That’s metabolic flexibility. That means cancer has changed and it’s switched its fuel sources and it’s doing different things. So, and then they give them another one and then another type of chemotherapy, and then it changes again. But at that time, you’re getting an increased lipid issue in the body, the guts getting wrecked, the immune system’s dropping. So, you know, you’re getting diminishing responses, you get diminishing returns on investing your health in that and everything about integration is kind of balancing that out. That’s what we aim to do. We aim to influence what happens with treatments and we aim to, you know, ensure that if they’re doing treatments, you know, keep going. Treatments don’t stop working or, you know, if they’re deciding not to use treatments, they have a viable option afterwards. Interesting.

Robin Daly
Yeah, it often strikes me as rather interesting how the language of genetics has sort of provided a bridge in as much as that, you know, you could say the whole alternative world came from a metabolic perspective, as I said, there’d been people doing metabolic treatments for cancer as long as I know. And the whole of orthodox medicine has been talking genetics, genetics, genetics all the time. So, you know, from the way the evidence has gone, genetics doesn’t seem to have won the day as what cancer is really all about, but there’s a mass of genetic information now which is useful, and particularly when it comes to dealing with the energy pathways and things, there’s lots of useful information there.

Patricia Peat
Yeah. I think as well, I find that the way genetics are talked about by the medical profession is it doesn’t describe it well because people think genetics are fixed. It’s often that. People are still saying, oh, I’ve got the BRCA gene. We’ve all got the BRCA gene. It’s a mismatch repair gene. It protects us against cancer. When it’s doing that, it’s balanced. When you are told you have the BRCA gene, it means it’s overexpressing. We know that a lot of things can influence genetic expression on the complementary side, on the integrative side, that we can promote, upgrade the expression of genetics. I’ve switched on and switched off like P53 for an example, which is your first nod defense. So people kind of think of genes that you’ve got a gene, but actually the proper way to understand genetics is balance and switching on, switching off. You can be her too positive with breast cancer. You can become her too negative. That’s only something that’s been understood the last 10 years. But I don’t think that comes across well. That is real power for people because that then brings in, and I know you’ve got your break conference in October on this, that then brings in all the things that promote good genetics, not just the metabolics, but meditation and massage and all those things. Yeah, absolutely.

Robin Daly
Yeah, there’s so much there. Yeah, anyway, I was very much struck by the kind of the way that I’ve heard recently of people going into see their oncologist was something that they want to do. And they produced the reason why genetically is a good thing for them to do. And this has made much more impression than these things normally do that, you know, they’ve actually had a positive response from their oncologist, because they can see, oh, yeah, there’s the evidence is kind of positively influenced this genetic situation, which is a problem. And, you know, that I just very struck how it’s got to provided a common language, which is respected by both sides. And

Patricia Peat
Yes. Yeah. We’ve found a middle ground of conversation.

Robin Daly
Yeah, it is. Of course, that’s what I’m looking for all the time. You are too. We want to find this middle ground because integration requires the end of hostilities, because everybody’s got to communicate, they’ve got to collaborate for the sake of the patient. That’s the essence of what good medicine, that’s what we’re looking for, is patient-centered care.

Patricia Peat
ideal scenario is that team approach. It’s not about who’s in charge, who’s got egos. Everybody has a contribution. I sent a client to her oncologist recently. She’s got hormonal breast cancer and we looked at all the hormonal methylation pathways. I don’t want oncologist down. He says, well, that’s interesting. I haven’t looked at the methylation pathways since I was in medical school. Which is kind of, oh, okay. Worrying. Yeah, but the level of interest, the more we, we can’t get doctors to change their minds unless we can, for evidence in front of them, unless we can put research in front of them. One of the people we’ve got talking at her conference, Professor Walter Longo, is very much doing studies and that’s what’s got to go. The big question, we’ve got to move that back one bit. There’s two issues with that as we move things forward, Robin. Most definitely, as I’ve always said, we have to measure the method, not just minimalistically take out one element and sort of say, how does that perform against cancer? Because it’s not about one thing, it’s about many things. We’ve got to do that and then you’ve got to ask the other question, where’s the research money going to come from? Professor Dalby, she’s doing a research into low-dose naltrexone, and he’s having to raise 60 million.

Robin Daly
That’s your entry point. 60 million.

Patricia Peat
That’s the point at which you’re going to impress somebody. He’s an amazing man, he’ll do it. But if it comes to, okay, we need the studies, we need to be able to put a massive amount of research in front of people, you’ve got to look at the amount of money that’s going into cancer research. Can we have some of that, please?

Robin Daly
Yeah, it’s got to be diverted. I agree. And I think, again, I’m hearing examples of where that’s happening, where money is being channeled into something which is right in our territory. It isn’t being channeled in there because it has the prospects of vast returns and all this kind of thing. It’s actually because it looks like sound science and it’s worth supporting. So I think that’s great. And I think the more it happens, the more it will happen. So I’m hoping that that divert will get firmly in place and a nice flow of cash will start going in the right direction.

Patricia Peat
Yeah. And the other big thing that we need, which is my big passion, is we need practitioners working with people with cancer. You know, it’s very much a thing in the UK that a nutritionist in that part, et cetera, when they train the toll, don’t get work with people with cancer because you might get it wrong. You might make a mistake. And, you know, I set up the it is a labyrinth. It’s a lot. It’s a lot of information. When someone’s diagnosed and the mind is blown away by what they’re dealing with, to then research and look into integrative things and sort themselves out is a very big ask. So we need someone to sit with them and interpret and do all that. And, you know, so I am very much encouraging, you know, sort of positivity and confidence in working with people with cancer. It can be done in a very safe, systematic way that’s enormously helpful. And my new project, because I just needed another one. Of course. I was doing nothing after lunch. But no, this is one of the things that I’m hoping is going to follow change is one of the big issues as well is we keep going, oh, there’s lots of evidence. You know, I’ve been collecting research done is that, you know, 30 years, you know, go, oh, there’s lots of evidence. Yeah. Where is it? Well, generally, it’s all over the place. It’s here. It’s that, you know, Jane Richland brought together a fantastic amount. Yes. But, you know, that, you know, when practitioners want to work safely in the public, want to look safer, they want to go to a source of information that sort of says, yeah, OK, this is all been this is the information you need. So, you know, I’m working with the company and we are getting, you know, basically they’re building a massive database, very, very high tech. There’s going to check interactions, there’s going to bring research, you know, so that people will sort of say, OK, you know, Jeff has got prostate cancer, you know, he’s got P10 deletion. So that means his coding switched on. Amazing. Metabolism. And he’s got this going off and that going off, you know, what are the right approaches, what are the pathways, et cetera. This is all going to get churned out. OK, these are all the right things. This is what you kind of need to focus on. Yeah. Yeah. Yeah. Which is going to be great. When he started, that’s a biggie. That’s a biggie, God.

Robin Daly
So, look, you mentioned in passing there the match with the Peat Institute, which of course the next thing I wanted to talk about, so come on, what, why, when, where, let’s have all, all the low down.

Patricia Peat
you know, I would at some time like to retire. But, yeah, it would be an enormous shame if, you know, I had no format. It was all in my head and my computer. I had no formatted way of that. So that’s essentially that of really to, you know, to get people involved, to move things forward, do it in a very supportive way. You know, we have our courses, but we also do mentorship meetings and I do one-to-ones. So, you know, I’ll talk to somebody before they speak to a client. I’ll talk to them afterwards. So they’ve got the reassurance of knowing that, you know, they get in the oncology side because, you know, I find cancer absolutely fascinating. But, you know, it is a lot to learn. So we’re providing them with that professional backup. So say, yeah, this, you know, this is pancreatic cancer. This is what’s going to happen. This is what’s going to happen with the, you know, the pancreatic enzymes and the bile. And these are the potential problems they’re going to face. So we’ve got strategies for everything. So, yeah. So that’s the Pewter Institute. And, yeah, it’s great. And it’s another lovely community. It really is. Our students are fantastic. We all learn from each other. I’m getting next week’s ready. And it’s a client I’ve got who’s with an aggressive brain tumor. Not that they’re not very often unaggressive, but we are now getting on for about three years on with no recurrence, which is great. And a couple of things that come up on tests. Yeah, I know, I love it. A couple of things that come up on tests that I’d kind of say, oh, that’s not real. I don’t think that’s to do with cancer. So I’m taking it to my students. Can you sort this out for me? Yeah, you know, you get injections of the knowledge from everywhere, which is fantastic. So it’s enormous fun, actually.

Robin Daly
Okay, so you better tell us a bit about what’s involved and what the entry requirements are.

Patricia Peat
Oh, the entry requirements are essentially to have a background in nutrition, naturopathy, to have some training in functional medicine to a degree, just to have that baseline, et cetera, of understanding nutrition and metabolics to a degree. And then we have our foundation course, we have our specialist courses that I’m constantly enlarging on. And we bring all that in, then every month we cover a different cancer subject. And we’ve got a whole library of things that we’ve covered over the last two years available on video for people. So they contact the Pete Foundation, they can do the foundation course because you’ve got to have an understanding of cancer and how it metabolizes, et cetera. And it’s done at your own pace. I don’t want to… Practitioners are very busy. You know, I like people to… People will gather interest once they start to get into cancer and working with cancer. It’s like, well, that’s so interesting. And this is interesting. So we kind of drag them in and take them along and watch their interest grow. And it’s wonderful watching their confidence actually. Because they come from like, oh, I don’t like anything wrong.

Robin Daly
it is nice to get them feeling well enough in form to actually confidently be able to work in that way. So it’s online, it’s at your own pace, so that’s true also, the foundation course, you can do that over WAP.

Patricia Peat
Yeah, all that is and then we have our live sessions every month and that’s

Robin Daly
They’re in addition to that.

Patricia Peat
Yeah, they’re in addition to that. So there’s continual support and mentorship. Yeah, we don’t just, you know, it’s a bit like our clients, we’re continually working with our clients. You know, people always need to be supported. And they will have the excited things like our conference coming up in September, which is brilliant.

Robin Daly
All right, let’s hear about that then.

Patricia Peat
Uh, so conferences September international conference Uh, i’ve been working on this for a couple of years now And it is it’s going to be in person in london and it’s also going to be available online around the world And it is entitled metabolic flexibility integrative oncology in action because I wanted to theme it around this because because Everything we do it comes down to two things with cancer. Doesn’t it? It comes down to The environment of the body being favorable to deal with cancer Either during treatment or after treatment So making sure that’s supported and it comes down to not allowing cancer to metabolic flexibly go down different pathways So that’s what everybody’s working up as I said People don’t really understand metabolic flexibility in art, but you know the law so we are literally theming this throughout so the law that you Understand Metabolic flexibility the more you understand what the aims and objectives are of what you’re doing So nature winters is speaking of chords

Robin Daly
Fantastic.

Patricia Peat
Yeah. Also the metabolic approach to cancer, the terrain. I talk about the body’s environment. She’s all about the terrain. She is. And she talks about how people are metabolically inflexible, but cancer is, this is why cancer is metabolically inflexible, become more. We’ve got, speaking in person, so speaking in person, we’ve got Nahesha, we’ve got Mark itself. We’ve got Dr. Thomas Durage, who works at the Seat Freeds Clinic. So the founders, metabolic therapies, covering ketogenic diet, bioenergetic metabolism. He’s published a lot of peer reviewed papers. And we have Dr. Abdul Slocum from Chemothermia Clinic, which is literally integrative oncology in action. So they’re oncologic clinic. They’ve literally put this into action to tackle metabolic flexibility to get cancer to respond.

Robin Daly
You actually worked with Pumeth and me, it must be for something like six or seven years now, is that right?

Patricia Peat
Well, I don’t sort of work with anybody. I’m independent, but I yeah, you know, I know that I mean you’ve had an ongoing dialogue and you’ve been

Robin Daly
referring people there, and so you’ve got experience with them, let’s say, for some years.

Patricia Peat
Absolutely. And, you know, he mirrors what we are trying to achieve in terms of working alongside, you know, they will take a resistant person who’s built up a lot of resistance and turn it around. And that’s the important thing is no matter, one thing is what you throw at cancer, but the other is getting it to work. That’s the theme of the whole conference, getting it to work. And then I’ve got some amazing speakers and we’re running alongside this and available to anybody who, you can come online, you can come in person. We’ve got a whole series of interviews that I’m doing with other specialists around the world. So we’ve broadened out immensely. So, you know, we’ve got Mark Linton, who you know very well. I do know him very well. You do, author of The Cancer Resolution, which is that amazing book, a new piece of research, which is actually getting to that, what is the feedback loop? Metabolic flexibility, what is protecting cancer cells and what is allowing them to survive and then come back again, which is whatever, you know, everything’s aimed at. His work is amazing. And it’s bang on in keeping with what I’m seeing in clinical trials around the world, which I haven’t got time to go into. We’ve got Professor Saadford Deeler, from the Overton Institute in America. The Overton Institute, do you remember Nicholas Gonzales, the Gonzales Protocol, many years ago. That was around one of my first, when I first got going. He sadly died some years ago, but that is now researched as a metabolic treatment. Jay McClelland, of course, who everybody knows or should know, et cetera. Professor Carol Zaccura, who’s an oncologist, who’s written a new book, The Key to Getting the Best Cancer Care, making the system work for you from an oncologist.

Robin Daly
No, I think he has a genuine interest in patients’ wellbeing and he takes a very intelligent and reasoned approach.

Patricia Peat
he does. He’s very, very, yeah, he’s always been very supportive. He’s an old friend of mine, loving to bits. He used to say to, he once said at a conference in London, my hardest clients are the ones that Patricia Pete sends me because she doesn’t want me to do anything to them before I scan them, which is true. So I love him. We’ve got Dominique Ken, who’s co-author of the Ketogenic Kitchen. But as a client of mine, she’s a breast cancer survivor. We’re looking from her perspective that she got diagnosed with cancer, so they went nutrition is so important. We’ve got professors, there’s so much here in this conference. Professor Serge Uranus, who is an award-winning professor from Portugal, who really focus on, does amazing research and work on P53 and cell immortality. So what is keeping cells going? Volta Lango, I mentioned, nutrition, fasting, mimicking, diet, et cetera. Dr. Elizabeth Thompson, CEO for the National Center for Integrative Medicine. He’s one of the driving forces for integrative approaches in the UK and around the world. They are all doing about 40, 45 minute interviews that are there for people to watch at their leisure. To every one of those has got an amazing contribution to make in terms of people’s understanding of cancer and the different things that they can do against it. So the whole aim is that with our conferences, that people will come away with a vast amount of knowledge and it’s open to the public, it’s open to practitioners. I’m very keen that I think we haven’t got enough practitioners working with cancer, so I don’t want information to stop with practitioners. I want the public to be able to access because they become their own experts. And it’s hopefully just going to be the most amazing conference and amazing day in Europe. Well, it’s so

Robin Daly
he sounds like it and yeah it’s something to go to. So are you able to book yet? I did so where?

Patricia Peat
Yeah, you are a website integrated action. We’re really going to tell the story of integration oncology. We’re going to tell the whole story of metabolics and cancer and how it’s developed. I’m going to provide so many research studies and references that are going to be there for people. So I’m hoping that people come away informed and empowered and really, realize the value of what they can do for themselves.

Robin Daly
It certainly sounds like it. Okay, any quick pointers for where you see things going in the next few years for the Pete Institute?

Patricia Peat
Well, I see, you know, with a convention that you’ve brilliantly instigated setting up some scientific boards where, you know, experts, I think it was something that movement’s going to get bigger, Robin. We are starting to congregate, thanks to your good work and other people’s, whereby they kind of the main leaders in integrative oncology are coming together to bring information together to research to evaluate ourselves, you know, because one of my things is always, I’m evaluating for people, you know, is that, does that make sense, is it safe, you know, is it clinically reasonable to do, and we’re going to bring all that stuff under one roof to some extent so that, you know, we’re going to move, continue to move further and further away from any kind of protocols or strategies that are really not coming from a good science place, that are really not, really not a sensible thing for people to do, and we’re going to continue to move to positive, safe action that is actually making, you know, making an incredible difference against cancer.

Robin Daly
Great. All right. Well, we’re gonna leave it there. Thanks so much for coming on the show today

Patricia Peat
Pleasure, thank you very much for inviting me, Robin, as always.

Robin Daly
It’s so good to talk about this onward march of integration. For you and me, it’ll probably always be too slow, but I think there’s little doubt that it’s going in the right direction now as it is actually moving at last.

Patricia Peat
It absolutely is. And momentum is picking up enormously. We need to get that information to the public and we need the public. They’re the ones who are bringing about change. Always. They really will talk to the wrong colleges and sort of say, look, this is what I’m doing really well. This is what I’m doing.

Robin Daly
If you’re interested to know more about the conference Patricia was introducing on the 23rd of September, Metabolic Flexibility, Integrative Oncology in Action, then go to nutritioncollective.co.uk where you can read more about the event and book tickets. Mark Valentin’s book The Cancer Resolution is published by Amazon and if you’ve not come across this work before, I definitely recommend you look into it. Mark has also been my guest in a series of interviews for the yestolife show so look out for him on the radio show page of yestolife.org.uk where you can search for him by name, Mark Linton. There’s another opportunity to hear Patricia speak and to meet her at the yesterlife annual conference on the 7th of October in Euston, London. She will be one of the many experts giving talks and leading workshops at the event, which is a companion to our hugely popular online summer conference that many of you may have attended last month. They jointly go under the title of You and Your Cancer Team and you can look at the full schedule and the lineup of speakers as well as book places on the conference website, which is yestolifeannualconference.org. Thanks very much for listening to the show today. I shall be back again next week with another yestolife show.